NIAGEN BIOSCIENCE, INC. Disposal Group, Including Discontinued Operation, Revenue
NIAGEN BIOSCIENCE, INC. (NAGE) reported Disposal Group, Including Discontinued Operation, Revenue of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-07.
Discontinued › Income Statement › Other Income
us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue · last filed 2019-03-07
- NIAGEN BIOSCIENCE, INC. disposal group, including discontinued operation, revenue for the quarter ending 2017-12-30 was $369.00, a 99.97% decline year-over-year.
- NIAGEN BIOSCIENCE, INC. disposal group, including discontinued operation, revenue for the quarter ending 2017-09-30 was $650.61K, a 39.20% decline year-over-year.
- NIAGEN BIOSCIENCE, INC. disposal group, including discontinued operation, revenue for the quarter ending 2016-12-31 was $1.19M.
- NIAGEN BIOSCIENCE, INC. disposal group, including discontinued operation, revenue for the quarter ending 2016-10-01 was $1.07M.
- NIAGEN BIOSCIENCE, INC. disposal group, including discontinued operation, revenue for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- NIAGEN BIOSCIENCE, INC. disposal group, including discontinued operation, revenue for fiscal 2017 was $2.82M, a 45.19% decline from fiscal 2016.
- NIAGEN BIOSCIENCE, INC. disposal group, including discontinued operation, revenue for fiscal 2016 was $5.15M, a 24.63% increase from fiscal 2016.
- NIAGEN BIOSCIENCE, INC. disposal group, including discontinued operation, revenue for fiscal 2016 was $4.13M.
| Period end | Disposal Group, Including Discontinued Operation, Revenue 3 month | Disposal Group, Including Discontinued Operation, Revenue 6 month | Disposal Group, Including Discontinued Operation, Revenue 9 month | Disposal Group, Including Discontinued Operation, Revenue 12 month | Disposal Group, Including Discontinued Operation, Revenue 12 month as first filed |
|---|---|---|---|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-03-07 | ||||
| 2017-12-30 | $369.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $650.98K derived: sum of 2 quarters · filed 2019-03-07 | $2.82M 10-K · filed 2019-03-07 | $2.82M 10-K · filed 2018-03-15 | |
| 2017-09-30 | $650.61K 10-Q · filed 2017-11-09 | $2.82M 10-Q · filed 2017-11-09 | |||
| 2016-12-31 | $1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $2.26M derived: sum of 2 quarters · filed 2018-03-15 | $5.15M 10-K · filed 2018-03-15 | ||
| 2016-10-01 | $1.07M 10-Q · filed 2017-11-09 | $3.96M 10-Q · filed 2017-11-09 | |||
| 2016-01-02 | $4.13M 10-K · filed 2018-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |